Bedel Financial Consulting, Inc. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$54,000
+134.8%
630
-1.6%
0.03%
+125.0%
Q2 2020$23,000
+155.6%
6400.0%0.01%
+100.0%
Q1 2020$9,000
-35.7%
6400.0%0.01%
-25.0%
Q4 2019$14,000
+75.0%
6400.0%0.01%
+60.0%
Q3 2019$8,000
-11.1%
640
+1.6%
0.01%0.0%
Q2 2019$9,000
-25.0%
6300.0%0.01%
-37.5%
Q1 2019$12,000
+33.3%
6300.0%0.01%
+33.3%
Q4 2018$9,000
-30.8%
6300.0%0.01%
-33.3%
Q3 2018$13,000
-13.3%
6300.0%0.01%
-18.2%
Q2 2018$15,000
+66.7%
6300.0%0.01%
+57.1%
Q1 2018$9,0006300.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders